C.Pneumonia IVD FIA Rapid Quantitative Test Kit WWHS Wide-Range Diagnostics Technology

Summary

Chlamydia pneumoniae is an important pathogen of respiratory infection, it can cause upper

respiratory tract infection,such as sinusitis, otitis and pharyngitis, and lower respiratory tract

infection, such as bronchitis and pneumonia.The Diagnostic Kit is a simple, visual qualitative test

that detects Cpn-Igm in human whole blood, serum or plasma. The Diagnostic Kit is based on

immunochromatography and can give a result within 15 minutes.

Applicable instrument
Except visual inspection, the kit can be matched with Continuous immune analyzer NIR-1000

Assay Procedure

The NIR-1000 test procedure see the instruction of Continuous immune analyzer. Visual test procedure is as follows
1.Take out the test card from the foil bag, put it on the level table and mark it;
2.Add 10μl serum or plasma sample or 20ul whole blood sample to sample well of the card with provided dispette, then add 100μl (about 2-3 drop) sample diluent; start timing;
3.Wait for a minimum 10-15 minutes and read the result, the result is invalid after 15 minutes.

Characteristics

1. Accurate: Double antibody sandwich method, high sensitivity.
2. Rapid: Get results in 15 minutes.
3. Convenient: No need professional training, test could be performed at any time, any place.

Why Choose Us

1. Precision
Deviation is less than 3.0%
2. Upgraded data storage
10000 data storage
3. Long life
Support to use 3 years

Interpretation of Test Results

1. The kit can be used for auxiliary test only. If test result is abnormal, retest timely and judge combined with clinical symptoms.
2. For samples whose cTnI concentration is lower than 0.1ng/mL and higher than 40ng/mL, test result is “＜0.1ng/mL” and “＞40ng/mL” respectively.

About WWHS Biotech Inc

WWHS Biotech. Inc Is A High-Tech Enterprise Incubated By The Research Institute Of Tsinghua University In Shenzhen In 2016. The Company Is Located In The National Biomedical Industrial Base In Pingshan District, Shenzhen, With About 32,000 Square Feet Space For Workshop And Office.

As A Fast-Growing Biotechnology Company, We Dedicate To The Development Of World-Class Bio-Detection Technologies That Meet The Ever-Increasing Demands On Clinical Diagnostics. We Focus On Developing Cost-Effective And Precise Rapid Diagnostic Products Based On Our Unique Near Infrared (NIR) Fluorescence Platform Technologies (PGOLD™ And IR-LF™) With Major Interests In Cardiology, Infectious Diseases, Oncology, Metabolic Diseases And Women And Children’s Health.